The need for multicentre cardiovascular clinical trials in Asia

被引：0
|
作者：
Joey S. W. Kwong
Cheuk-Man Yu
机构：
[1] Institute of Vascular Medicine,Heart Education And Research Training (HEART) Centre and Division of Cardiology, Department of Medicine and Therapeutics
[2] Li Ka Shing Institute of Health Sciences,undefined
[3] S. H. Ho Cardiovascular Disease and Stroke Centre,undefined
[4] Prince of Wales Hospital,undefined
[5] The Chinese University of Hong Kong,undefined
来源：
Nature Reviews Cardiology | 2013年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this opinion article, the authors discuss multicentre clinical trials in Asia. Asians have been under-represented in many clinical trials; differences in cardiovascular disease risk and drug responses between Asians and white people underscore the importance of ethnicity-specific intervention testing. Challenges specific to Asia need to be addressed before Asia can rival Europe and the USA as a location-of-choice for clinical trials.
引用
收藏
页码：355 / 362
页数：7
相关论文
共 50 条
  • [21] Recruitment time analysis in multicentre clinical trials
    Anisimov, V
    Fedorov, V
    Jones, B
    CONTROLLED CLINICAL TRIALS, 2003, 24 : 50S - 51S
  • [22] Model validity range in multicentre clinical trials
    Dragalin, V
    Fedorov, VV
    MODA6 ADVANCES IN MODEL-ORIENTED DESIGN AND ANALYSIS, 2001, : 53 - 61
  • [23] Multicentre randomised clinical trials in trauma care
    Rangan, A.
    Maffulli, N.
    JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2011, 93B (06): : 720 - 721
  • [24] Design of multicentre clinical trials with random enrolment
    Anisimov, Vladimir V.
    Fedorov, Valerii V.
    ADVANCES IN STATISTICAL METHODS FOR THE HEALTH SCIENCES: APPLICATIONS TO CANCER AND AIDS STUDIES, GENOME SEQUENCE ANALYSIS, AND SURVIVAL ANALYSIS, 2007, : 387 - +
  • [25] Managing multicentre clinical trials with open source
    Raptis, Dimitri Aristotle
    Mettler, Tobias
    Fischer, Michael Alexander
    Patak, Michael
    Lesurtel, Mickael
    Eshmuminov, Dilmurodjon
    de Rougemont, Olivier
    Graf, Rolf
    Clavien, Pierre-Alain
    Breitenstein, Stefan
    INFORMATICS FOR HEALTH & SOCIAL CARE, 2014, 39 (02): : 67 - 80
  • [26] Lessons to be learned from multicentre clinical trials
    Fairclough, DL
    Cella, D
    QUALITY OF LIFE RESEARCH, 1997, 6 (7-8) : 101 - 101
  • [27] Feasibility studies, clinical trials and multicentre collaboration
    Carole L. Turner
    Angelos G. Kolias
    Peter J. Hutchinson
    Acta Neurochirurgica, 2017, 159 : 11 - 12
  • [28] Why do clinical trials in Asia?
    林兆鑫
    ActaPharmacologicaSinica, 1998, (S1) : 6 - 6
  • [29] European views on clinical trials in Asia
    Khayat, David
    ANNALS OF ONCOLOGY, 2015, 26 : 6 - 6
  • [30] Ethical Considerations in Clinical Trials in Asia
    Noritoshi Tanida
    Drug information journal : DIJ / Drug Information Association, 2002, 36 (1): : 41 - 49
12345